According to Russian expert, JSC Rusatom Healthcare is at the forefront of ground-breaking innovations to make nuclear medicine and healthcare technology efficient, effective and affordable

Mumbai – Nuclear medicine is increasingly becoming crucial for diagnostics and therapy including thyroid owing to rapid innovations in technology. JSC Rusatom Healthcare has emerged as a leader in providing cutting-edge solutions for diagnostics and therapeutics, leveraging Rosatom Global’s years of experience and expertise in nuclear technology and innovation, according to Mr. Sergey Evdonin, Project Head, Rosatom Healthcare.

In a webinar organized by Rosatom for journalists from India and Bangladesh, Mr. Evdonin explained how nuclear medicine technology is being increasingly adopted across the world and demand for nuclear medicine products and solutions have seen rapid growth. Catering to this demand, Rusatom Healthcare, an integrator of the radiation technologies for medicine and industry

within Rosatom, offers a range of products with integrated solutions spanning project concept and development, design, construction, equipment manufacturing and supply, supply and installation of equipment, training of personnel, and service and maintenance.

Elaborating upon the products and solutions, Mr. Evdonin added that broadly, Rusatom Healthcare offers products and solutions in three broader categories; Diagnostic facilities, Therapeutic facilities, and Integrated solutions for GMP standard radiopharmaceutical production. In addition to off-the-shelf offerings, the solutions can be optimized and configured as per the needs of the customer.

Highlighting the benefits of the products, Mr. Evdonin stated that Positron emission tomography (PET)  diagnostics have proven to improve a number of indicators including 5-6 times decrease in the number of cancer recurrences, 15-20% increase in  the number of detected cancer cases , 30, 40% quality improvement of cardiovascular disease diagnostics, 5-30% reduction in cancer mortality through correct treatment.  In terms of therapeutic for nuclear medicine, Rusatom Healthcare’s products for Radionuclide therapy, Radiotherapy, Brachytherapy and Proton and ion beam therapy are being widely used across the world. Rusatom Healthcare JSC provides radiopharmaceuticals for molecular imaging, radionuclide therapy and diagnostics and is an supplies isotope products to more than 50 countries in the world enabling diagnosis and treatment of about 2.5 million people every year.

With regard to opportunities for India in using nuclear technology for non-energy generation purposes, Mr. Edvonin stated that Rusatom Healthcare is going to co-operate with local companies for delivery high technology solutions in medicine which will greatly enhance the efficiency of diagnostics in particularly oncological cases. He further added that nuclear technology can play a major role in reducing the agricultural produce waste, which is quite high in India, through Ionizing Radiation Treatment.

Concluding the webinar, Mr. Evdonin emphasized that more than 75 years of experience, expertise and learnings in nuclear technology has been applied to make the nuclear medicine products and solutions advanced, safe and effective. In addition to nuclear medicine, Rusatom is also providing project solutions for Ionizing Radiation Treatment of Products including food and agriculture products, medical products and polymer materials. Ionizing radiation treatment is helping in reducing food wastage by extending shelf life and pest control. Similarly, the radiation treatment for medical products guarantees a complete biological inactivation of bacteria contained in medical products with no residual radioactivity. Non-energy uses of nuclear technology is rapidly gaining pace across different categories including medicine and treatment of products and Rusatom Healthcare’s solutions would benefit in the wider adoption of nuclear medicine across the world.